Kissei Pharmaceutical Co Ltd
TSE:4547
Kissei Pharmaceutical Co Ltd
TSE:4547
Price:
3 140 JPY
0.64%
Market Closed
Updated:
May 16, 2024
Kissei Pharmaceutical Co Ltd
Interest Income Expense
|
Kissei Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
Interest Income Expense
¥10B
|
CAGR 3-Years
24%
|
CAGR 5-Years
57%
|
CAGR 10-Years
27%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥161.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥25.6B
|
CAGR 3-Years
136%
|
CAGR 5-Years
47%
|
CAGR 10-Years
96%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥3.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
See Also
What is Kissei Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
10B
JPY
10B
JPY
Based on the financial report for Mar 31, 2024, Kissei Pharmaceutical Co Ltd's Interest Income Expense amounts to 10B JPY.
What is Kissei Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
27%
27%
Over the last year, the Interest Income Expense growth was -32%. The average annual Interest Income Expense growth rates for Kissei Pharmaceutical Co Ltd have been 24% over the past three years , 57% over the past five years , and 27% over the past ten years .
You don't have any saved screeners yet
